PDS Biotechnology (PDSB) Earnings Date, Estimates & Call Transcripts $3.20 -0.01 (-0.31%) (As of 09/20/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 12EstimatedActual EPS (Aug. 13) -$0.23 Beat By $0.08 Consensus EPS (Aug. 13) -$0.31 Conference Call AudioEarnings Press Release Get PDS Biotechnology Earnings AlertsEnter your email address below to receive the latest news and earnings results for PDSB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePDSB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PDSB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Investors AlleyForget Trump and KamalaI hope you're deleting all those emails telling you how to make "1,000% gains" from the magic "Kamala Trade". It's nonsense. No one knows what's going to happen in November.THIS CALENDAR is the only thing that matters for you and your financial health right now. PDS Biotechnology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.40)($0.33)($0.37)Q2 20241($0.29)($0.29)($0.29)Q3 20242($0.33)($0.28)($0.31)Q4 20242($0.39)($0.34)($0.37)FY 20247($1.41)($1.24)($1.33)Q1 20251($0.37)($0.37)($0.37)Q2 20251($0.37)($0.37)($0.37)Q3 20251($0.39)($0.39)($0.39)Q4 20251($0.41)($0.41)($0.41)FY 20254($1.54)($1.54)($1.54)PDSB Earnings Date and InformationPDS Biotechnology last issued its quarterly earnings results on August 13th, 2024. The reported ($0.23) EPS for the quarter, topping analysts' consensus estimates of ($0.31) by $0.08. PDS Biotechnology has generated ($1.36) earnings per share over the last year (($1.36) diluted earnings per share). Earnings for PDS Biotechnology are expected to decrease in the coming year, from ($1.30) to ($1.42) per share. PDS Biotechnology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off prior year's report dates.Read More PDS Biotechnology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/12/2024(Estimated)------- 8/13/2024Q2 2024($0.31)($0.23)+$0.08($0.23)-- 5/15/2024Q1 2024($0.37)($0.30)+$0.07($0.30)-- 3/27/2024Q4 2023($0.39)($0.34)+$0.05($0.34)-- 11/14/2023Q3 2023($0.42)($0.35)+$0.07($0.35)-- 8/14/2023Q2 2023($0.37)($0.37)-($0.37)-- 5/15/2023Q1 2023($0.31)($0.32)($0.01)($0.32)-- Get the Latest News and Ratings for PDSB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PDS Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 3/28/2023Q4 2022($0.30)($0.67)($0.37)($0.67)-- 11/14/2022Q3 2022($0.26)($0.26)-($0.26)-- 8/8/2022Q2 2022($0.30)($0.20)+$0.10($0.20)-- 5/11/2022Q1 2022($0.24)($0.32)($0.08)($0.32)-- 3/31/2022Q4 2021($0.24)($0.23)+$0.01($0.23)-- 11/10/2021Q3 2021($0.22)($0.24)($0.02)($0.24)-- 8/11/2021Q2 2021($0.17)($0.03)+$0.14($0.41)-- 5/12/2021Q1 2021($0.19)($0.14)+$0.05($0.14)-- 3/18/2021Q4 2020($0.18)($0.16)+$0.02($0.16)--11/16/2020Q3 2020($0.14)($0.23)($0.09)($0.23)-- 8/13/2020Q2 2020($0.23)($0.19)+$0.04($0.19)-- 5/13/2020Q1 2020($0.15)($0.39)($0.24)($0.39)-- 3/27/2020Q4 2019-($0.52)($0.52)($0.20)--11/7/2019Q3($0.82)($1.10)($0.28)($1.10)-- PDS Biotechnology Earnings - Frequently Asked Questions When is PDS Biotechnology's earnings date? PDS Biotechnology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on PDSB's earnings history. Did PDS Biotechnology beat their earnings estimates last quarter? In the previous quarter, PDS Biotechnology (NASDAQ:PDSB) reported ($0.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.08. Learn more on analysts' earnings estimate vs. PDSB's actual earnings. How can I listen to PDS Biotechnology's earnings conference call? The conference call for PDS Biotechnology's latest earnings report can be listened to online. Listen to Conference Call How much profit does PDS Biotechnology generate each year? PDS Biotechnology (NASDAQ:PDSB) has a recorded net income of -$42.94 million. PDSB has generated -$1.36 earnings per share over the last four quarters. What is PDS Biotechnology's EPS forecast for next year? PDS Biotechnology's earnings are expected to decrease from ($1.30) per share to ($1.42) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Inovio Pharmaceuticals Earnings Results Fate Therapeutics Earnings Results Anavex Life Sciences Earnings Results Aquestive Therapeutics Earnings Results Taysha Gene Therapies Earnings Results GH Research Earnings Results Foghorn Therapeutics Earnings Results Canopy Growth Earnings Results Xeris Biopharma Earnings Results C4 Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:PDSB) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDS Biotechnology Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PDS Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
